These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19042967)

  • 41. Therapeutic effects of ml-236B in primary hypercholesterolemia. 1980.
    Yammoto A; Sudo H; Endo A
    Atheroscler Suppl; 2004 Oct; 5(3):43-50. PubMed ID: 15531274
    [No Abstract]   [Full Text] [Related]  

  • 42. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ezetimibe/simvastatin.
    Montecucco F; Quercioli A; Mach F
    Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almost.
    Steinberg D
    J Lipid Res; 2006 Jan; 47(1):1-14. PubMed ID: 16227628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a policy allowing for over-the-counter statins.
    Mainous AG; Baker R; Everett CJ; King DE
    Qual Prim Care; 2010; 18(5):301-6. PubMed ID: 21114910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stents, statins, and other dumb luck.
    Robbins P
    J Biol Chem; 2011 Jan; 286(3):1669-74. PubMed ID: 21098482
    [No Abstract]   [Full Text] [Related]  

  • 51. Reversal of neural and electrophysiologic remodeling in cardiac tissue.
    Ciaccio EJ
    Heart Rhythm; 2009 Jan; 6(1):76-7. PubMed ID: 19121804
    [No Abstract]   [Full Text] [Related]  

  • 52. The Discovery of Statins.
    Manu P; Rogozea L
    Am J Ther; 2016; 23(4):e980-1. PubMed ID: 27386961
    [No Abstract]   [Full Text] [Related]  

  • 53. A historical perspective on the discovery of statins.
    Endo A
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(5):484-93. PubMed ID: 20467214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statins for all.
    Neild GH
    Transplantation; 2000 May; 69(9):1767-8. PubMed ID: 10830204
    [No Abstract]   [Full Text] [Related]  

  • 55. Terje Rolf Pedersen, MD: a conversation with the editor. Interview by William Clifford Roberts.
    Pedersen TR
    Am J Cardiol; 1999 Nov; 84(10):1234-45. PubMed ID: 10569335
    [No Abstract]   [Full Text] [Related]  

  • 56. Underuse of statins among older people.
    De Wilde S; Cook DG; Carey IM; Hilton SR; Whincup PH
    Lancet; 2003 Aug; 362(9385):746-7. PubMed ID: 12957105
    [No Abstract]   [Full Text] [Related]  

  • 57. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I.
    Steinberg D
    J Lipid Res; 2004 Sep; 45(9):1583-93. PubMed ID: 15102877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Jim's view: What makes transformative basic science possible?
    Rothman JE
    FEBS Lett; 2019 Aug; 593(15):1877-1878. PubMed ID: 31301063
    [No Abstract]   [Full Text] [Related]  

  • 59. The controversy surrounding cholesterol treatment in older people.
    Alibhai SM; Rochon PA
    Geriatr Nephrol Urol; 1998; 8(1):11-4. PubMed ID: 9650042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Christopher John Dillon Packard, PhD: a conversation with the editor. Interview by William Clifford Roberts.
    Packard CJ
    Am J Cardiol; 1999 Nov; 84(10):1226-33. PubMed ID: 10569334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.